Broad Institute
Exact Sciences Releases Next-Gen Cologuard Data, Inks New Partnerships
The firm said the new version of its colon cancer screening test improved upon its predecessor across a variety of metrics, including both sensitivity and specificity.
Rolled out in partnership with Fabric Genomics, the test includes clinical WGS and variant analysis and interpretation services with a turnaround time of four weeks.
Broad Institute, Collaborators Eye CRISPR Panel to Detect SARS-CoV-2 Variants, Respiratory Viruses
Premium
The group has developed a panel to detect SARS-CoV-2, other coronaviruses, and influenza A and B that also identified and differentiated six variant lineages.
Ginkgo Bioworks Acquires Massachusetts COVID-19 Testing Firm
Project Beacon COVID-19 was started by F-Prime Capital, GV, and the Broad Institute to help implement COVID-19 testing in Massachusetts and its environs.
The point-of-care system can detect SARS-CoV-2 in unprocessed patient saliva in about an hour, according to the researchers.